Abstract
Phase II trial of very high dose cisplatin (DDP) and etoposide (VP-16) and mitomycin-C (Mito-C) in advanced non-small cell lung cancer (NSCLC) : P. Caguioa, P. Hesketh, S. Tansan, W. Baduel, A. Hesketh, D. Karp, N. DiMartino, R. Blanchard, K. Zaner and D. Carney. The Univ Hosp, Boston VA Med Ctr, Boston
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
